Does patient ambulation affect the induction to abortion internal in early medical termination of pregnancy up to 63 days gestation?

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2006
INTERVENTION: The participants will be randomly assigned to one of two groups. Group one will be required to remain on the ward and for the first hour following misoprostol administration will be confined to the recliner chair in a semi‐recumbent position. After misoprostol administration, Group two will be encouraged to mobilise immediately and following a fifteen minute observation period will be encouraged to leave the ward and walk around the hospital. Both patient groups will be encouraged to report first symptoms of cramping and first evidence of bleeding to the supervising nurse on the ward. All patients will be obliged to return to the ward when bleeding commences or after four hours, whichever is sooner. The time that products of conception are passed will be recorded. Data will be collated with respect to gestation and gravida to ensure a like with like comparison. Those patients who do not wish to participate will follow the current protocol which requires them to remain on the ward until the products of conception are passed. CONDITION: Pregnancy and Childbirth: Abortion ; Pregnancy and Childbirth ; Abortion PRIMARY OUTCOME: 1. The induction to abortion interval; 2. Hospital in‐patient time ie admission to discharge interval SECONDARY OUTCOME: Not provided at time of registration INCLUSION CRITERIA: Women attending for medical termination of pregnancy of gestation below 63 days. Medical termination of pregnancy at this gestation is known to be a safe and predictable procedure. Patients will be approached at clinic and the study explained verbally and written information outlining the study will be given. Patient involvement will be discussed after mifepristone administration and consent for inclusion in the study obtained. Patients will be able to withdraw from the study at any time.
Epistemonikos ID: 64800a78f4c990061fc171125e1f5644e085258f
First added on: Aug 21, 2024